There has been a flurry of developments regarding the massive number of hip implant lawsuits that have been filed against nearly two dozen manufacturers of the medical devices across the country over claims that patients have suffered serious hip implant medical problems.
In one of the most recent, Biomet lost its legal battle to prevent the consolidation of such lawsuits involving its M2a Magnum hip system in the U.S. District Court for the Northern District of Indiana. That decision means that a federal judge will oversee and consolidate a huge number of such cases and coordinate pre-trial evidence gathering and settlement talks.
Biomet argued against the consolidation, maintaining that the cases were not similar enough to be consolidated and involved a product that had not been the subject of a recall, as is the case in a similar federal court consolidation of the DePuy Orthopaedics ASR Hip Implant Products Liability Litigation involving that company’s metal-on-metal hip implants.
Read more at this website: http://www.resource4thepeople.com/defectivemedicaldevices/metal-hip-implants.html
Meanwhile, DePuy and 20 other manufacturers of the controversial metal systems have been ordered by the Food and Drug Administration to study the multiple problems associated with the devices and report back the findings.
The essential problem, as reported in individual complaints to the FDA and in allegations contained in hip implant lawsuits is that devices sold under brand such as DePuy, Biomet, Stryker, Rejuvenate and Prefemur fail prematurely.
Hip implant victims claim that the devices were poorly designed and marketed without adequate testing and warnings about dangerous side effects that could develop as early as a year after an implant. Among these issues, which have been acknowledged by the FDA, are that tiny fragments of metal debris from the systems have broken off and infected the victims’ bodies, causing severe pain, infections and damage to body organs and functions.
According to the wording in one Biomet suit, the implant’s metal-on-metal design is defective, as it can lead to premature failure and metallosis, said to be caused by the high levels of metal ions generated by the fragments.